KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
KYNB on Nasdaq
Shares outstanding
4,044,489
Price per share
$8.77
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,150,869
Total reported value
$10,102,517
% of total 13F portfolios
0%
Share change
+18,551
Value change
-$49,623
Number of holders
31
Price from insider filings
$8.77
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.9% +6% $3,508,000 +$192,940 400,000 +5.8% Armistice Capital, LLC 31 Dec 2025
VANGUARD GROUP INC 4.4% $916,888 178,040 The Vanguard Group 30 Jun 2025

As of 31 Dec 2025, 31 institutional investors reported holding 1,150,869 shares of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB). This represents 28% of the company’s total 4,044,489 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 9.9% 400,000 +5.8% 0.09% $3,512,000
VANGUARD GROUP INC 4.5% 181,973 -1.2% 0% $1,597,723
ACADIAN ASSET MANAGEMENT LLC 2.6% 105,585 -4.3% 0% $925,000
BlackRock, Inc. 2.1% 84,690 -0.07% 0% $743,579
TWO SIGMA INVESTMENTS, LP 1.5% 61,211 +52% 0% $537,433
GEODE CAPITAL MANAGEMENT, LLC 1.1% 43,704 +0.05% 0% $383,805
HighTower Advisors, LLC 0.98% 39,746 0% 0% $348,970
MARSHALL WACE, LLP 0.8% 32,502 -55% 0% $285,366
RENAISSANCE TECHNOLOGIES LLC 0.78% 31,681 +8.2% 0% $278,159
DRW Securities, LLC 0.75% 30,420 +171% 0.02% $267,087
TWO SIGMA ADVISERS, LP 0.56% 22,809 0% $200,263
STATE STREET CORP 0.5% 20,284 0% 0% $178,094
CITADEL ADVISORS LLC 0.41% 16,756 -29% 0% $147,117
NORTHERN TRUST CORP 0.32% 12,852 0% $112,841
JANE STREET GROUP, LLC 0.31% 12,497 0% $109,723
Squarepoint Ops LLC 0.3% 12,186 -26% 0% $106,993
ADAR1 Capital Management, LLC 0.26% 10,469 0.01% $91,918
Corient Private Wealth LLC 0.25% 10,013 0% $87,914
UBS Group AG 0.23% 9,432 +8.8% 0% $82,813
MORGAN STANLEY 0.15% 5,924 +283% 0% $52,012
GROUP ONE TRADING LLC 0.11% 4,588 -0.86% 0% $40,283
BANK OF AMERICA CORP /DE/ 0.01% 595 0% 0% $5,225
CIBC Private Wealth Group LLC 0.01% 287 0% 0% $2,520
Tower Research Capital LLC (TRC) 0.01% 216 -25% 0% $1,896
SBI Securities Co., Ltd. 0% 152 0% 0% $1,335

Institutional Holders of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,150,869 $10,102,517 -$49,623 $8.78 31
2025 Q3 1,132,318 $13,869,418 +$1,072,340 $12.25 30
2025 Q2 1,045,108 $5,537,068 +$5,536,814 $5.30 27